LSBPW
LakeShore Biopharma Warrants
LSBPW
LSBPW
Delisted
LSBPW was delisted on the 19th of September, 2025.
28 hedge funds and large institutions have $266K invested in LakeShore Biopharma Warrants in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
25% less capital invested
Capital invested by funds: $356K → $266K (-$89.3K)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Holders
28
Holding in Top 10
4
Calls
$33K
Puts
–
Top Buyers
| 1 | +$341 | |
| 2 | +$45 | |
| 3 | +$8 | |
| 4 |
CAC
Cowen and Company
New York
|
+$8 |
Top Sellers
| 1 | -$22.2K | |
| 2 | -$11.3K | |
| 3 | -$2.42K | |
| 4 |
ETH
Exos TFP Holdings
New York
|
-$1.86K |
| 5 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$1.49K |